Fresenius SE & Co. (OTCMKTS:FSNUY) Issues Quarterly Earnings Results

Fresenius SE & Co. (OTCMKTS:FSNUY) announced its quarterly earnings data on Wednesday. The company reported $0.28 earnings per share (EPS) for the quarter, Zacks reports. Fresenius SE & Co. had a net margin of 5.26% and a return on equity of 9.72%. The business had revenue of $6.94 billion during the quarter.

Fresenius SE & Co. Stock Down 0.8%

Shares of FSNUY traded down $0.13 during midday trading on Thursday, reaching $15.09. 1,153 shares of the stock were exchanged, compared to its average volume of 54,109. The company has a market capitalization of $34.00 billion, a P/E ratio of 27.44 and a beta of 0.75. The company has a current ratio of 1.26, a quick ratio of 0.99 and a debt-to-equity ratio of 0.49. Fresenius SE & Co. has a 52 week low of $9.78 and a 52 week high of $33.93. The company’s 50 day moving average is $14.56 and its two-hundred day moving average is $14.40.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on the company. Citigroup reissued a “buy” rating on shares of Fresenius SE & Co. in a research note on Tuesday, February 3rd. Morgan Stanley reiterated an “overweight” rating on shares of Fresenius SE & Co. in a research report on Monday, December 15th. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Fresenius SE & Co. presently has a consensus rating of “Buy”.

About Fresenius SE & Co.

Fresenius SE & Co KGaA is a global healthcare group headquartered in Bad Homburg vor der Höhe, Germany. Founded in 1912 by Eduard Fresenius, the company has grown into one of the world’s leading providers of products and services for dialysis, hospitals and outpatient medical care. Trading on major European exchanges and available over the counter in the U.S. as FSNUY, Fresenius SE & Co brings together a portfolio of specialized healthcare businesses under one corporate umbrella.

The company operates through four main business segments.